Kei Nagai

Estimating the prevalence of definitive chronic kidney disease in the Japanese general population

Kei Nagai, Koichi Asahi, Kunitoshi Iseki et al. · Clinical and Experimental Nephrology · 2021 · 70 citations

Medicine, Nephrology, Clinical Epidemiology +8

Histamine‐1 receptor is not required as a downstream effector of orexin‐2 receptor in maintenance of basal sleep/wake states

Mari Hondo, Kei Nagai, Kinji Ohno et al. · Acta Physiologica · 2009 · 59 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration

Naoya Totsuka, Yun‐Gi Kim, Kazumasa Kanemaru et al. · Nature Communications · 2014 · 28 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis

Poh‐Yi Gan, Amy J. Chan, Joshua D. Ooi et al. · Kidney International · 2019 · 27 citations · Full text

Medicine, Immunology, Nephrology +14

Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study

Toshiyuki Imasawa, Chie Saito, Hirayasu Kai et al. · Nephrology Dialysis Transplantation · 2022 · 23 citations

Medicine, Family Medicine, Nephrology +14